No Data
No Data
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching
Stifel Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $90
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Stifel Nicolaus Sticks to Its Buy Rating for Edwards Lifesciences (EW)
RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected